Pharmacogenetically based dosing of thiopurines in childhood acute lymphoblastic leukemia: Influence on cure rates and risk of second cancer

Mette Levinsen; Elisabeth Orskov Rotevatn; Susanne Rosthøj; Jacob Nersting; Jonas Abrahamsson; Malin Lindqvist Appell; Stein Bergan; Anne-Grete Bechensteen; Arja Harila-Saari; Mats Heyman; Olafur Gisli Jonsson; Jakob Bernhard Cohn Maxild; Mikko Niemi; Stefan Soderhall; Kjeld Schmiegelow

doi:10.1002/pbc.24921

Pharmacogenetically based dosing of thiopurines in childhood acute lymphoblastic leukemia: Influence on cure rates and risk of second cancer

Mette Levinsen, Elisabeth Orskov Rotevatn, Susanne Rosthøj, Jacob Nersting, Jonas Abrahamsson, Malin Lindqvist Appell, Stein Bergan, Anne-Grete Bechensteen, Arja Harila-Saari, Mats Heyman, Olafur Gisli Jonsson, Jakob Bernhard Cohn Maxild, Mikko Niemi, Stefan Soderhall, Kjeld Schmiegelow

Section of Biostatistics

20 Citations (Scopus)

Original language	English
Journal	Pediatric Blood & Cancer
Volume	61
Issue number	5
Pages (from-to)	797-802
ISSN	1545-5009
DOIs	https://doi.org/10.1002/pbc.24921
Publication status	Published - May 2014

Keywords

ALL
late effects of cancer treatment
outcomes research
therapy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/pbc.24921

Cite this

Levinsen, M., Rotevatn, E. O., Rosthøj, S., Nersting, J., Abrahamsson, J., Appell, M. L., Bergan, S., Bechensteen, A.-G., Harila-Saari, A., Heyman, M., Jonsson, O. G., Maxild, J. B. C., Niemi, M., Soderhall, S., & Schmiegelow, K. (2014). Pharmacogenetically based dosing of thiopurines in childhood acute lymphoblastic leukemia: Influence on cure rates and risk of second cancer. Pediatric Blood & Cancer, 61(5), 797-802. https://doi.org/10.1002/pbc.24921

Levinsen, M, Rotevatn, EO, Rosthøj, S, Nersting, J, Abrahamsson, J, Appell, ML, Bergan, S, Bechensteen, A-G, Harila-Saari, A, Heyman, M, Jonsson, OG, Maxild, JBC, Niemi, M, Soderhall, S & Schmiegelow, K 2014, 'Pharmacogenetically based dosing of thiopurines in childhood acute lymphoblastic leukemia: Influence on cure rates and risk of second cancer', Pediatric Blood & Cancer, vol. 61, no. 5, pp. 797-802. https://doi.org/10.1002/pbc.24921

@article{33a7c956d9cf46c2ae0a00d8a71624fd,

title = "Pharmacogenetically based dosing of thiopurines in childhood acute lymphoblastic leukemia: Influence on cure rates and risk of second cancer",

keywords = "ALL, late effects of cancer treatment, outcomes research, therapy",

author = "Mette Levinsen and Rotevatn, {Elisabeth Orskov} and Susanne Rosth{\o}j and Jacob Nersting and Jonas Abrahamsson and Appell, {Malin Lindqvist} and Stein Bergan and Anne-Grete Bechensteen and Arja Harila-Saari and Mats Heyman and Jonsson, {Olafur Gisli} and Maxild, {Jakob Bernhard Cohn} and Mikko Niemi and Stefan Soderhall and Kjeld Schmiegelow",

year = "2014",

month = may,

doi = "10.1002/pbc.24921",

language = "English",

volume = "61",

pages = "797--802",

journal = "Pediatric Blood & Cancer",

issn = "1545-5009",

publisher = "JohnWiley & Sons, Inc.",

number = "5",

}

TY - JOUR

T1 - Pharmacogenetically based dosing of thiopurines in childhood acute lymphoblastic leukemia

T2 - Influence on cure rates and risk of second cancer

AU - Levinsen, Mette

AU - Rotevatn, Elisabeth Orskov

AU - Rosthøj, Susanne

AU - Nersting, Jacob

AU - Abrahamsson, Jonas

AU - Appell, Malin Lindqvist

AU - Bergan, Stein

AU - Bechensteen, Anne-Grete

AU - Harila-Saari, Arja

AU - Heyman, Mats

AU - Jonsson, Olafur Gisli

AU - Maxild, Jakob Bernhard Cohn

AU - Niemi, Mikko

AU - Soderhall, Stefan

AU - Schmiegelow, Kjeld

PY - 2014/5

Y1 - 2014/5

KW - ALL

KW - late effects of cancer treatment

KW - outcomes research

KW - therapy

U2 - 10.1002/pbc.24921

DO - 10.1002/pbc.24921

M3 - Journal article

C2 - 24395436

SN - 1545-5009

VL - 61

SP - 797

EP - 802

JO - Pediatric Blood & Cancer

JF - Pediatric Blood & Cancer

IS - 5

ER -

Pharmacogenetically based dosing of thiopurines in childhood acute lymphoblastic leukemia: Influence on cure rates and risk of second cancer

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this